FSD Pharma Says Celly Nutrition Partners With Six+One for US Launch of Dietary Supplement
FSD Pharma (HUGE) said Thursday that Celly Nutrition has partnered with branding agency Six+One to collaborate on the launch of its dietary supplement unbuzzd in the US. As part of the collaboration,
MT NewswiresApr 25 13:50 ET
FSD Pharma's Unbuzzd Gears Up for U.S. Launch
TipRanksApr 25 08:07 ET
FSD Pharma Provides Update From Celly Nu's Partnership With Six+One For Beverage Product Unbuzzd
On April 25, 2024, Celly Nu announced a strategic partnership with Six+One, a purpose-driven branding, advertising, and production agency based in New York City. FSD Pharma has also licensed unbuzzd,
BenzingaApr 25 07:58 ET
FSD Pharma Gears Up for Unbuzzd US Launch
TipRanksApr 22 08:38 ET
FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of Unbuzzd(TM)
On April 22, 2024, Celly Nu announced a strategic partnership with BevSource, a leading provider of beverage development, production and operations solutions in St. Paul, Minnesota as follows.
AccesswireApr 22 08:02 ET
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Welcome to Benzinga's psychedelic headlines roundup. This is our pick of must-read news items from the first two weeks of April 2024.See previous edition Psychedelics Headlines: A Form Of Life, Treati
BenzingaApr 17 09:13 ET
Express News | FSD Pharma Says It Has Initiated Investigations Into Ingredients And Dietary Supplements That May Have The Potential To Promote Weight Loss And Liver Health
Moomoo 24/7Apr 17 08:05 ET
FSD Pharma Increases Stake in Recovery Drink Innovator
TipRanksApr 15 08:47 ET
FSD Pharma Provides Update on Its Investment in Celly Nutrition Corp., a Company Launching a Product That Can Assist in Expediting Alcohol Metabolism and Faster Recovery From Alcohol Consumption
On April 8, 2024, Celly Nu announced an investment by FSD complete press release is referenced below;
AccesswireApr 15 08:03 ET
Express News | 'FDA Head Says There's 'No Reason For DEA To Delay' Rescheduling Marijuana' - Marijuana Moment
Moomoo 24/7Apr 11 14:14 ET
FSD Pharma Faces Nasdaq Compliance Challenge
TipRanksApr 9 17:28 ET
FSD Pharma Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Seeking AlphaApr 8 05:52 ET
FSD Pharma Receives Nasdaq Non-Compliance Notice
FSD Pharma (HUGE) said it received an April 5 notice from Nasdaq informing it that the company has fallen out of compliance with rules requiring a $1 minimum share price for being listed on the exchan
MT NewswiresApr 8 04:58 ET
FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Toronto, Ontario--(Newsfile Corp. - April 7, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfoli
newsfileApr 7 22:55 ET
FSD Pharma GAAP EPS of -$0.46
Seeking AlphaApr 2 06:00 ET
FSD Pharma Reports Year-End Financials & R&D Progress
TipRanksApr 1 22:37 ET
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Welcome to Benzinga's psychedelic headlines roundup. This is our pick of must-read news items from the last two weeks of March 2024.See previous edition Psychedelics Headlines: Substitution Survey, Fr
BenzingaMar 30 08:57 ET
'GOP Senators Tell DEA To Reject Marijuana Rescheduling, Arguing It Would Violate International Treaties' - Marijuana Moment
Three Republican senators are urging the Drug Enforcement Administration (DEA) to reject the top federal health agency's marijuana rescheduling recommendation, arguing that it would put the U.S. out o
BenzingaMar 27 11:44 ET
FSD Pharma Advances MS Treatment With New Study
TipRanksMar 27 08:47 ET
FSD Pharma Brief: Signed Agreement With INGENu CRO To Conduct a Clinical Study To Assess Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 (Lucid-MS) in Healthy Adults
08:03 AM EDT, 03/27/2024 (MT Newswires) -- FSD Pharma Brief: Signed Agreement With iNGENu CRO To Conduct a Clinical Study To Assess Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-
MT NewswiresMar 27 08:03 ET
No Data
No Data